Liposomal Bupivacaine Pharmacokinetic Study After Median Sternotomy Incision Infiltration in a Pediatric Cardiac Surgery
Status:
Recruiting
Trial end date:
2023-01-06
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the plasma concentration of bupivacaine at various
time points after Exparel (bupivacaine liposome injectable suspension, Pacira
Pharmaceuticals, Inc., Parsippany, NJ) is injected subcutaneously for median sternotomy
incisions in pediatric cardiac surgery patients.